Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CAPS > SEC Filings for CAPS > Form 8-K on 21-Nov-2013All Recent SEC Filings

Show all filings for CAPSTONE THERAPEUTICS CORP.

Form 8-K for CAPSTONE THERAPEUTICS CORP.


21-Nov-2013

Results of Operations and Financial Condition, Regulation FD Disclosu


Item 2.02 Results of Operations and Financial Condition.

On November 12, 2013, Capstone Therapeutics Corp. filed their financial results for the third quarter ending September 30, 2013 on Form 10-Q with the Securities Exchange Commission.

On November 12, 2013, Capstone Therapeutics Corp. issued a press release announcing its Quarterly Operating Update conference call and webcast to be held on Thursday, November 21, 2013 at 4:30 pm EST.

A copy of the slide presentation for the conference call referenced in the press release entitled "Capstone Therapeutics Corp. Operating Update, November 21, 2013," is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 2.02 of this Form 8-K and Exhibit 99.1 furnished herewith shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in any such filing.



Item 7.01. Regulation FD Disclosure.

On November 12, 2013, Capstone Therapeutics Corp. issued a press release announcing its Quarterly Operating Update conference call and webcast to be held on Thursday, November 21, 2013 at 4:30 pm EST. The call may be accessed at 877-303-2908 (U.S.), 408-427-3860 (outside U.S.); accompanying slides may be viewed by logging onto the Investors section of the Company's website www.capstonethx.com. A replay will be available beginning November 21, 2013 at 7:30 pm EST until midnight November 23, 2013 and may be accessed at 855-859-2056 (U.S.) or 404-537-3406 (outside U.S.) with conference ID 11067828.

A copy of the slide presentation for the conference call referenced in the press release entitled "Capstone Therapeutics Corp. Operating Update, November 21, 2013," is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The presentation will also be accessible during the conference call by logging onto the Investors section of the Company's website, www.capstonethx.com.

The information in Item 7.01 of this Form 8-K and Exhibit 99.1 furnished herewith shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in any such filing.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Capstone Therapeutics Operating Update, November 21, 2013


  Add CAPS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CAPS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.